Search Results
Results found for "Xavier Periole"
- Ep 50 with Dr. Thomas P. Sakmar
simulations and coarse-grain sampling approaches for membrane proteins in collaborations with Thomas Huber , Xavier Periole , and Siewert-Jan Marrink .
- Unveiling Non-Canonical Functions for Gαq Signaling Pathways
During this period and her doctoral thesis, she has deepened the regulatory mechanisms of GPCR signaling In her postdoctoral period, she has participated in the identification and characterization of proteins
- Weekly News October 23 | Dr. GPCR Ecosystem
GPCR Weekly News - Oct 23 - The Power and Peril of Irreversible Drugs Published on October 23, 2025 Category
- Ep 118 with Dr. David Sykes
During this period David has made a significant contribution to the understanding of agonist/ antagonist
- Ep 117 with Dr. Pierre Eftekhari
During my Scholar period I have published or contributed in 38 published scientific work mainly in the
- Ep 80 with Dr. Andrew Tobin
Following a post-doctoral period at Bristol Myers Squibb in Princeton USA, Andrew returned to the UK
- What’s one key piece of advice from Ian Chronis in Ep.164 of the Dr.GPCR Podcast?Listen to other scientists’ research—it’s a great way to stay motivated and inspired 🚀 Don’t miss this insightful conversation on GPCRs, pharmacology, and scientific discovery! ✅ https://buff.ly/FTB69y9 #GPCR #DrGPCR #SciencePodcast #Pharmacology #CancerResearch | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- The GPCR world is waiting to see YOU. Update your profile today and be part of the biggest GPCR community in the world 🌏 ✳️Visit https://www.ecosystem.drgpcr.com/account/my-account and share your updated information 😉 #gpcr #drgpcr | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- Seeking to gain more knowledge on signaling bias? We’ve got the perfect opportunity for you 🚀 Registrations open until February 14th ⚠️ Last spots available for “The Practical Assessment of Signaling Bias” with Dr. Terry Kenakin ✳️Register today at https://www.ecosystem.drgpcr.com/event-details-registration/the-practical-assessment-of-signaling-bias #gpcr #drgpcr | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- Did you know allosteric modulators can change the GPCR G protein subtype selectivity? Have a look at this study to dive deep into its molecular mechanism. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox. | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- Adenosine A3 receptor has been proposed to have significant roles in metabolism and immune responses. Check out this study to understand how it affects metabolic dysfunction-associated steatotic liver progression. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://buff.ly/42b6ra3 #gpcr #drgpcr | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- Exploring the combination of molecular simulation, pharmacological assays, and NMR to reveal the molecular mechanism of biased activation at the vasopressin V2 receptor. Did you know that we work hard to bring you the most recent GPCR News, weekly? Catch up today in the Ecosystem using your free site membership! | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- In case you haven’t heard, our next Dr.GPCR University course is open for registrations 🙂 Learn about "The Practical Assessment of Signaling Bias" with Dr. Terry Kenakin. 🙌 Hands-on exercises included! ✳️Only 25 spots available ➡️Enjoy a 25% discount with your Premium Membership https://www.ecosystem.drgpcr.com/event-details-registration/the-practical-assessment-of-signaling-bias #gpcr #drgpcr | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- Dr. GPCR University Vault | Dr. GPCR Ecosystem
Period. Anonymous This looks super useful for drug discovery!
- GPCR Weekly News | Dr. GPCR Ecosystem
GPCR News 3 min read Get Premium for Full Access Latest Issue The Power and Peril of Irreversible Drugs
- master gpcr pharmacologic models before its too late | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- 🚀 New Workshop: Practical Quantification of Allosteric Modulation Join Dr. Terry Kenakin on May 1st, 2025, for an advanced live workshop on allosteric modulators in GPCR drug discovery. Learn how to: ✔️ Identify, measure, and quantify allosteric properties ✔️ Apply functional allosteric models to determine mechanisms of action ✔️ Confirm allostery through kinetic analysis 📅 Date: May 1st, 2025 ⏳ Registration deadline: April 18th 📍 Live on Google Meet 🔗 Register now: https://www.ecosystem.drgpcr.com/event-details-registration/practical-quantification-of-allosteric-modulation #GPCR #Allostery #DrugDiscovery #Pharmacology | Dr. GPCR Ecosystem
That’s the power (and the peril) of irreversible drugs. These aren’t just “stronger binders.”
- Privacy Policy | Dr. GPCR Ecosystem
Please review this policy periodically.
- News | Dr. GPCR Ecosystem
More October 2, 2025 Read More September 18, 2025 Read More Contributors Articles Kiyan Afzali The Perils
- Ep 154 with Dr Badr Sokrat
He highlighted that he had to regain his confidence after a period of three failed experiments.
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
GPCR Weekly News - Oct 23 - The Power and Peril of Irreversible Drugs October 23, 2025 GPCR Weekly News
